When Jim Cramer slaps a “buy” on a stock, the real question isn’t whether he likes it. It’s whether you’re early — or you’re the exit ramp. So let’s talk about Marvell (MRVL) and Bausch Health (BHC). Two very different companies. Two very different setups. And two very different levels of risk if you’re chasing…